Sickle Cell Consortium

Analysis

Sickle Cell Consortium is a registered charity in United States, based in Cumming, GA. It received its IRS tax-exemption ruling in August 2015, 11 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Sickle Cell Consortium reported income of $918k and spending of $1.0m, spending 111% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $325k to $918k (+183%), an average of +30% a year. The sharpest change came in the year to December 2021, when income rose by 96%. Over the whole period it spent 97% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Sickle Cell Consortium sits at the 63rd percentile: it is larger than about 63% of them. Against every charity in United States with reported income it ranks in the 78th percentile, and in the 82nd percentile within GA. Charities of a similar size with the same main cause include West Central Minnesota Ems Corporation ($918k), Coram Deo Inc ($919k) and Recon Inc ($918k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $104k (10% of expenses). At year end it held assets of $124k against liabilities of $0, net assets of $124k.